Plain-English translation of NCT06437522 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new two-drug combination called plus a to treat people with head and neck cancer that has come back or spread to other parts of the body. The medication is given as an infusion (dripped into your vein). Researchers want to see if this treatment works well and is safe for patients who don't have other good options.
Head and neck cancers that return or spread are very hard to treat, and many patients need better treatment options. This medication combines two types of cancer-fighting drugs in a way that hasn't been fully tested yet, and researchers hope it may work better than existing treatments.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would receive the medication as an intravenous infusion (through a vein in your arm) in 3-week cycles. If the treatment is helping and you can tolerate it, you may continue receiving additional cycles. During the trial, you will have regular visits for blood tests, scans, and check-ins with your doctor to monitor how well the medication is working and watch for any side effects. The treatment will be stopped if your cancer progresses, if side effects become too severe, or for other medical reasons.
AI-generated summary from trial data ยท Aug 8, 2026 ยท Not medical advice
China